eFlow rapid Nebuliser System with eBase® Controller

Patients worldwide benefit from clinically tested eFlow^® Technology

The eFlow^®rapid nebuliser system is suitable for the treatment of a wide range of diseases of the lower airways. It is used for an efficient and fast inhalation in long-term treatment.

The eFlow membrane technology offers short nebulisation time [1]
Small, lightweight, mobile and silent for discreet use
Hygiene: easy to clean and disinfect
Display provides feedback during inhalation
High lung dose correlates with good efficacy with standard nebuliser solutions [2,3]

[1] Naehrig S et al. Eur J Med Res 2011; 16(2): 63-6
[2] Beck-Broichsitter, M. J Pharm Sci, 2017. 106(8): p. 2168-2172
[3] Beck-Broichsitter M et al. Eur J Pharm Biopharm 2014; 87(3): 524-9

Aerosol characteristics of the eFlow^®rapid nebuliser system

MMAD^a):	4,7 µm
Respirable Fraction^a) < 5 µm:	53,8 %
Aerosol Output Rate^b):	0,43 g/min

Aerosol data according to ISO 27427; nebulised medium: Salbutamol 2.5 ml. Measured values may vary depending on the medication used. Recommended fill volume: see package leaflet for the medication.

^a) Measurement with Next Generation Pharmaceutical Impactor (NGI) at 23 °C and 50% relative humidity. Inspiratory flow: 15 l/min

^b) Measurement with breathing simulator at 23 °C and 50 % relative humidity. 500 ml breathing volume, breathing frequency 15 cycles/minute, sinusoidal breathing pattern, inhalation/exhalation ratio 1:1 (with adults, may vary in children).

For more technical information please see the Instructions for use.